BusinessImmune Therapeutics Redeems $656,250 Convertible Note; Company Actively Working to Strengthen Balance Sheet by Year EndBy Nasdaq OMXNov 15, 2016, 2:06 PM UTC
BusinessMyDx CEO Expects Profitability, New Era of Growth and Expansion in Special Letter to ShareholdersBy Nasdaq OMXNov 10, 2016, 2:43 PM UTC
BusinessMyDx Launches OrganaDx™ to Test for Pesticides & Heavy Metals in Cannabis and Food for SafetyBy Nasdaq OMXOct 27, 2016, 4:18 PM UTC
